Botox vs Xeomin: Key Differences, Benefits, and Cosmetic Uses

Choosing between Botox and Xeomin can feel confusing because they sound so similar. Both are injectable neuromodulators. Both soften expression lines. Both use botulinum toxin type A. Yet they are not identical, and the small differences can matter when planning cosmetic treatment.

The right choice usually comes down to the treatment area, personal response, provider preference, and medical history. Some people do beautifully with either option. Others may prefer one because of how it settles, how long it lasts, or how their body responds over time.

This guide explains how Botox and Xeomin compare, including their ingredients, cosmetic uses, side effects, duration, and unique benefits. This article is for general education only and should not replace medical advice from a licensed clinician.

Botox and Xeomin are both neuromodulators, but their formulations are not the same.

Botox and Xeomin share the same core purpose

Botox and Xeomin are both injectable treatments used to relax targeted facial muscles. In cosmetic care, that muscle relaxation can soften lines caused by repeated facial movement.

These are often called dynamic wrinkles. They appear or deepen when the face moves, such as when someone smiles, squints, frowns, or lifts the eyebrows. Over time, those expression lines may become visible even when the face is relaxed.

Common cosmetic concerns include:

• Frown lines between the eyebrows

• Crow’s feet around the eyes

• Horizontal forehead lines

• Bunny lines on the nose

• Chin dimpling

• Neck bands

• A gummy smile

• Downturned mouth corners

• Jawline slimming in select cases

  
  

Not every use has the same regulatory status. In the United States, Botox Cosmetic has FDA approvals for moderate to severe frown lines, crow’s feet, and forehead lines in adults. Xeomin is FDA approved for temporary improvement in moderate to severe glabellar lines, the vertical frown lines between the brows, in adults.

Clinicians may use either product in other cosmetic areas when they believe it is appropriate. This is known as off-label use, and it is common in aesthetic medicine. Off-label does not automatically mean unsafe, but it does mean the provider’s training, anatomy knowledge, and judgment matter a great deal.

Their active ingredients are similar, but the formulas are different

The biggest difference starts with the formulation.

Botox contains onabotulinumtoxinA, a form of botulinum toxin type A. Xeomin contains incobotulinumtoxinA, also a form of botulinum toxin type A.

Both active ingredients come from the same general category, but the surrounding proteins differ.

Botox includes the active neurotoxin along with accessory proteins. These proteins are part of the complete formulation. Xeomin is often described as a “naked” or purified neurotoxin because it does not contain the same accessory proteins around the active molecule.

That difference is one reason some providers may suggest Xeomin for people who seem to respond less predictably to other neuromodulators. The idea is that a simpler protein profile may reduce the chance of the body forming neutralizing antibodies. True resistance to cosmetic neuromodulators is considered uncommon, but it can happen.

Botox	Xeomin
Contains onabotulinumtoxinA	Contains incobotulinumtoxinA
Includes accessory proteins	Does not contain the same accessory proteins
Long history of cosmetic use	Purified formulation is its key distinction
FDA approved for frown lines, crow’s feet, and forehead lines	FDA approved for frown lines between the brows

The unit measurements for these products are specific to each brand. Even when dose conversions look similar in practice, patients should not treat them as interchangeable. A trained injector chooses the dose based on the product, muscle strength, anatomy, and desired result.

A thoughtful consultation helps match the product to the treatment goal.

How both treatments work under the skin

Botox and Xeomin work by temporarily blocking nerve signals to selected muscles.

When a nerve tells a muscle to contract, it releases a chemical messenger called acetylcholine. Botulinum toxin type A interferes with that release. The treated muscle then contracts less strongly. As the muscle relaxes, the overlying skin creases less during facial movement.

The goal in cosmetic treatment is not to “freeze” the entire face. Good results usually look smoother but still natural. A skilled injector uses small, strategic doses to soften lines while preserving expression.

For example:

• Treating the glabella can reduce the “11” lines between the eyebrows.

• Treating crow’s feet can soften crinkles that appear when smiling.

• Treating the forehead can smooth horizontal lines while keeping the brows balanced.

• Treating the chin can reduce a pebbled or dimpled look.

• Treating the masseter muscles can slim the lower face in select candidates.

  
  

Placement matters as much as product choice. A few millimeters can change the outcome, especially near the eyes and brows. Too much product in the wrong area may create heaviness, asymmetry, or an unnatural look.

This is why the best comparison is rarely just Botox vs Xeomin as products. The more useful question is which product, dose, and placement fit the face being treated.

Cosmetic uses can overlap, but each option has its strengths

Botox and Xeomin can treat many of the same expression-related concerns, especially in the upper face. Both are widely used for frown lines. Both can create a smoother, more rested appearance when used well.

Still, each option has benefits that may make it more appealing in certain situations.

Botox offers broad familiarity and a long cosmetic track record

Botox is probably the best-known neuromodulator in the United States. Many people use “Botox” as shorthand for the whole category, even when referring to another injectable.

Its strengths include:

• Brand recognition

  
  

Many patients have heard of it and feel comfortable asking for it by name.

• Multiple cosmetic approvals

  
  

Botox Cosmetic is approved for frown lines, crow’s feet, and forehead lines in adults.

• Broad treatment experience

  
  

Many injectors have extensive experience with Botox across different facial areas.

• Predictable planning

  
  

Because it has been used for years in cosmetic care, providers often know how it behaves in a wide range of patients.

Botox can be a strong choice for someone starting neuromodulator treatment for the first time, especially when the treatment plan includes several upper-face areas.

Xeomin has a cleaner formulation with fewer added proteins

Xeomin’s main distinction is its purified formulation. It contains the active neurotoxin without the same accessory proteins found in Botox.

Its strengths include:

• No accessory proteins

  
  

This may appeal to patients who prefer a more purified formulation.

• Potential option after reduced response

  
  

Some providers consider Xeomin when a patient feels their results from another neuromodulator are not lasting or working as expected.

• Natural-looking softening

  
  

When dosed well, Xeomin can soften frown lines without a heavy look.

• Storage convenience for practices

  
  

Before reconstitution, Xeomin can be stored without refrigeration, which can be useful for clinics. This does not usually affect the patient experience, but it is a practical distinction.

Xeomin is often chosen for glabellar lines, especially when someone wants a straightforward treatment for frown lines between the brows.

Dynamic lines form where repeated facial movement folds the skin.

Results appear gradually and last for a similar amount of time

Botox and Xeomin do not work instantly. Most people begin to notice changes within a few days, with full results usually appearing within about one to two weeks.

Some patients feel Xeomin “kicks in” a little faster, while others notice no timing difference. The onset can vary based on dose, muscle strength, metabolism, treatment area, and individual response.

For both options, cosmetic results often last about three to four months. Some people metabolize neuromodulators faster and see movement return sooner. Others enjoy results a bit longer, especially after consistent treatments over time.

The duration may depend on:

• The area treated

• The number of units used

• How strong the treated muscles are

• The person’s metabolism

• Exercise habits and lifestyle factors

• How often treatments are repeated

• The injector’s placement and technique

  
  

A first treatment may feel like a test run. The provider can see how the muscles respond, then refine the dose at future visits. Many people schedule maintenance treatment before full movement returns, but the right timing varies.

More product does not always mean a better result. Higher doses may last longer in some areas, but they can also increase the chance of heaviness or an overtreated look. The goal should be balanced movement, not simply maximum relaxation.

Side effects are usually mild, but risks deserve attention

Both Botox and Xeomin have similar possible side effects because they belong to the same medication class.

Common short-term effects may include:

• Redness at the injection site

• Mild swelling

• Tenderness

• Bruising

• Headache

• Temporary tightness or heaviness

• Minor asymmetry while the product settles

  
  

These effects often improve on their own. Bruising risk can vary based on skin type, injection area, medications, supplements, and how easily someone bruises.

Less common cosmetic side effects may include eyelid drooping, brow heaviness, uneven smile, dry eyes, watery eyes, or an unwanted change in expression. These issues are usually temporary, but they can be frustrating while they last.

Rare but serious risks can occur if toxin effects spread beyond the treatment area. Medical labeling for botulinum toxin products includes warnings about symptoms such as trouble swallowing, speaking, or breathing. Anyone with those symptoms after treatment should seek medical care right away.

A provider should review medical history before treatment. Special caution may be needed for people who:

• Are pregnant or breastfeeding

• Have a neuromuscular disorder

• Have had a reaction to botulinum toxin products

• Have an active infection near the treatment area

• Take medications that affect muscle or nerve signaling

• Have a history of significant eyelid drooping or facial weakness

  
  

Aftercare instructions vary, but many clinicians recommend avoiding rubbing the treated area right after injections. They may also suggest skipping strenuous exercise, alcohol, or lying flat for a short period after the appointment. Follow the specific instructions given by the treating clinician.

Simple aftercare can help reduce irritation and support a smooth recovery.

Choosing between Botox and Xeomin comes down to fit

There is no universal winner. Botox and Xeomin are both respected cosmetic injectables with strong uses. The best option depends on the face, the goal, and how the person responds.

Botox may be a better fit when someone wants a widely known option with multiple cosmetic approvals and a long track record across forehead lines, crow’s feet, and frown lines. It is also a familiar choice for people who have used it before and liked the result.

Xeomin may be a better fit when someone wants a purified formulation without accessory proteins, especially for glabellar lines. It may also be considered when past results with another neuromodulator seemed weaker than expected, though the cause should be evaluated carefully.

A good consultation should cover:

• Which areas bother the patient most

• Whether the lines are dynamic, static, or both

• Past injectable history

• Desired level of movement

• Medical history and contraindications

• Expected onset and duration

• Possible side effects

• Follow-up timing

  
  

Static lines, which remain visible when the face is fully relaxed, may not disappear with neuromodulators alone. They may improve over time if movement softens, but deeper etched lines may require other treatments such as resurfacing, microneedling, or fillers. A provider can explain what is realistic.

Cost may also play a role. Pricing can vary by region, provider, product, and number of units used. Comparing only the price per unit can be misleading because the treatment plan and injector skill both affect the final result.

Botox and Xeomin work best when they are part of a thoughtful plan rather than a quick product choice. The most important decision is choosing a qualified medical provider who understands facial anatomy, uses authentic products, and creates results that match the person’s features.

A smooth, natural-looking result comes from the right product in the right place at the right dose. Botox and Xeomin can both get there. The better choice is the one that fits the treatment goal, medical history, and response over time.